Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Technology

General health

Online since 17 January 2025, updated 111 days ago

About this trial

This feasibility trial is enrolling 2 individuals with cervical spinal cord injury who were previously enrolled in the BrainGate2 clinical trial (NCT00912041). If included, participants will use their previously implanted device (BrainGate2) to enable brain-computer interface (BCI) control of tablet-based communication applications. BCI is s technique using a computer and connected electrodes in the brain to record and decode brain activity thus allowing control of external devices. Final assessment of feasibility will be performed after 1 year.

Included participants

Gender

All

Age

18 - 80 years

Injury level

C1 - T1

Severity (AIS)?

Time since injury

All

Healthy volunteers

C1-T1

Additionally, participants must

have participated in the previous BrainGate2 trial (NCT00912041)

What’s involved

Type

Technology

Details

- Participants will use their existing device (BrainGate2) for brain-computer interface (BCI) control of tablet-based communication applications. - BCI is s technique using a computer and connected electrodes in the brain to record brain activity and also to control an external device. - Final assessment of feasibility will be performed after 1 year.

Potential benefits

Main benefits

General health

Additional benefits

Mental health and psychosocial factors

Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

Wings for Life supports SCITrialsFinder

Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

Learn more

Back to results